Article
Excision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancer.
The Journal of surgical research - 15 Jun 2011
Okuda Katsuhiro, Sasaki Hidefumi, Hikosaka Yu, Kawano Osamu, Yukiue Haruhiro, Yano Motoki, Fujii Yoshitaka
Abstract excerpt
BACKGROUND: It has been reported that the expression of excision repair cross-complementation group 1 (ERCC1) protein predicts the effect of platinum-based chemotherapy and overall survival in the several cancers. And there are some reports suggesting that the polymorphism of the ERCC1 may predict the effect of platinum-based chemotherapy and survival of the patients. We have already reported that the expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.